Definition of Imfinzi. Meaning of Imfinzi. Synonyms of Imfinzi

Here you will find one or more explanations in English for the word Imfinzi. Also in the bottom left of the page several parts of wikipedia pages related to the word Imfinzi and, of course, Imfinzi synonyms and on the right images related to the word Imfinzi.

Definition of Imfinzi

No result for Imfinzi. Showing similar results...

Meaning of Imfinzi from wikipedia

- Durvalumab, sold under the brand name Imfinzi, is an anti-cancer medication used for treatment of various types of cancer. It was developed by Medimmune/AstraZeneca...
- product alert warning that counterfeit versions of the immunotherapy drug IMFINZI (durvalumab) had been identified in Lebanon, Turkey, and Armenia. These...
- dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Durvalumab (Imfinzi) is an immune checkpoint inhibitor that blocks the PD-L1 protein on the...
- maint: overridden setting (link) "Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with unresectable liver cancer". AstraZeneca...
- illegal importation of certain cancer drugs – likely including Enhertu, Imfinzi and Imjudo – from Hong Kong. Following Russia's invasion of Ukraine in...
- skin cancer. Avelumab was developed by Merck KGaA and Pfizer. Durvalumab (Imfinzi) is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks...
- counterfeit cancer drugs, including fake immunotherapy medication like IMFINZI (durvalumab), through Beirut’s airport. These medicines contained no active...
- imelasomeran (INN) imepitoin (INN) imetelstat (USAN, INN) imexon (INN) Imfinzi imiclopazine (INN) imidafenacin (INN) imidapril (INN) imidaprilat (INN)...
- carcinoma. It failed phase III clinical trials for gastric cancer. Durvalumab (Imfinzi) is a fully human IgG1 antibody developed by AstraZeneca. Durvalumab is...
- Information. 22 (1). hdl:10665/74120. "Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with unresectable liver cancer". AstraZeneca...